Ultrasonic auricular vagus nerve stimulator using cannabinoid-containing coupling fluid

Inventors: Stanley Ward Stephenson (Spencerport, NY); Jonathan Taylor Hacker (Rochester, NY); Andrew Robert Slegaitis (Forestport, NY)

Assignee: NeurGear, Inc.

A61N7/00 A61M35/10 H04R1/1008 H04R1/1075 A61M2210/0662 A61N2007/0026

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 12702869
App. No.: 19/302,941
Granted: Aug 11, 2026
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

A headset apparatus for a user comprising an ultrasound transducer mounted to the headset apparatus, wherein the ultrasound transducer is configured to press against the auricular vagus nerve, a coupling fluid on the surface of the transducer permitting ultrasonic energy to pass into human skin and, a cannabinoid extract in solution with the coupling fluid.

Claims (24)

1 . A headset apparatus adjustable for one or more users to wear comprising:

(a) an ultrasound transducer mounted to said apparatus, wherein said ultrasound transducer is configured to press against an ear of said one or more users;

(b) a cannabinoid-containing coupling fluid on a surface of said ultrasound transducer, wherein said cannabinoid-containing coupling fluid comprises at least one cannabinoid selected from the group consisting of cannabidiol (CBD), tetrahydrocannabinol (THC), and cannabinol, and wherein said cannabinoid-containing coupling fluid that facilitates transmission of ultrasonic energy into human skin while delivering said at least one cannabinoid to tissue at or near an auricular vagus nerve; and

2 . The headset apparatus of claim 1 , wherein said cannabinoid-containing coupling fluid is a solution that contains cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol, or combinations thereof.

3 . The headset apparatus of claim 1 , wherein said cannabinoid-containing coupling fluid further comprises a vitamin, amino acid, peptide, essential oil, herbal extract, anti-inflammatory agent, analgesic, or combinations thereof.

4 . The headset apparatus of claim 1 , wherein said cannabinoid-containing coupling fluid is a solution that contains tetrahydrocannabinol (THC) with at least one carrier wherein said carrier is water, glycerine, or a combination of water, glycerine and one or more emulsifiers.

5 . The headset apparatus of claim 1 , wherein said cannabinoid-containing coupling fluid is a solution that contains cannabinol as a terpene.

6 . The headset apparatus of claim 1 , wherein said at least one cannabinoid of said cannabinoid-containing coupling fluid is in solution with at least a second component.

7 . The headset apparatus of claim 6 , wherein said at least one cannabinoid is in solution with one or more vegetable fluids.

8 . The headset apparatus of claim 1 , wherein said at least one cannabinoid is incorporated into a conformal pad that is selectively removable from said headset apparatus.

9 . The headset apparatus of claim 8 , wherein a cannabis infused conformal pad is selectively removable from said headset apparatus.

10 . A method for using an adjustable headset apparatus for one or more users to wear comprising:

(a) providing an ultrasound transducer mounted to said headset apparatus, wherein said ultrasound transducer is configured to press against an ear of said one or more users;

(b) applying a cannabinoid-containing coupling fluid to a surface of said ultrasound transducer, wherein said cannabinoid-containing coupling fluid comprises at least one cannabinoid selected from the group consisting of cannabidiol (CBD), tetrahydrocannabinol (THC), and cannabinol, to facilitate transmission of ultrasonic energy into human skin; and

(c) delivering said at least one cannabinoid to tissue at or near an auricular vagus nerve during application of ultrasound energy.

11 . The method of claim 10 , wherein said cannabinoid-containing coupling fluid is a solution that contains cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol, or combinations thereof.

12 . The method of claim 10 , wherein said cannabinoid-containing coupling fluid further comprises a vitamin, amino acid, peptide, essential oil, herbal extract, anti-inflammatory agent, analgesic, or combinations thereof.

13 . The method of claim 10 , wherein said cannabinoid-containing coupling fluid is a solution that contains tetrahydrocannabinol (THC) with at least one carrier wherein said carrier is a gel, water, glycerine, or a combination of gel, water, glycerine and one or more emulsifiers.

14 . The method of claim 10 , wherein said cannabinoid-containing coupling fluid is a solution that contains cannabinol as a terpene.

15 . The method of claim 10 , wherein said at least one cannabinoid of said cannabinoid-containing coupling fluid is in solution with at least a second component.

16 . The method of claim 15 , wherein said at least one cannabinoid is in solution with one or more vegetable fluids.

17 . The method of claim 16 , wherein a cannabis containing fluid is incorporated or infused into a conformal pad.

18 . The method of claim 17 , wherein said user of said cannabis conformal pad can selectively remove said conformal pad from said apparatus.